Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-07

Clinical Trial Update: FCM Versus R-FCM Followed by R-Maintenance or Observation Only [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FCM vs R-FCM followed by R-maintenance or observation in follicular and low-grade lymphomas; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FCM (ferric carboxymaltose)
  • R-FCM
  • R-maintenance

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Lymphoma, Follicular, Lymphoma, Low-Grade | Phase 3 | Status: UNKNOWN